The Waterloo Road actor appeared on This Morning and revealed he is turning to lifestyle changes to help manage his condition ...

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS): Osteoarthritis. NIAMS: Rheumatoid Arthritis.

Germany's biologics market, the largest in Europe, is expected to grow at a 3.8% CAGR from 2025 to 2035. AI is driving this growth by enhancing R&D, optimizing drug design, and identifying novel ...

Early treatment escalation to biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) following methotrexate (MTX) failure in new-onset rheumatoid arthritis (RA) does not ...

A recent study by Maheen Asif and team unveiled great outcome of abatacept in delaying the progression of rheumatoid ...

Differences in rates of bDMARD treatment initiation among US veterans with RA living in rural vs urban areas cannot be fully explained by location.

The clinical transition of these programs into the expansion enrollment stage is an important milestone highlighting safety for both drugs, stat ...

By limiting joint damage, disability is reduced. The primary treatment for rheumatoid arthritis is medication to reduce immune system activity and inflammation. Five categories of drugs commonly used ...

In recent years treatment with powerful biologic and targeted synthetic therapies has changed the landscape for arthritis, but currently finding the right treatment for each person is a matter of ...

Pharmaceutical Cartridges Market Driven by rising demand for self-administered therapies & advanced drug delivery systems, the <a target ...